Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

NCT03611686 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT03611686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03611686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Active, not recruiting
Start date
April 17, 2018
Completion date
April 30, 2026
Enrollment
219 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate adenocarcinoma